Cymbalta and Arachnoid cyst - a phase IV clinical study of FDA data

Summary:

Arachnoid cyst is reported as a side effect among people who take Cymbalta (duloxetine hydrochloride), especially for people who are female, 50-59 old, have been taking the drug for < 1 month also take Linzess, and have Multiple sclerosis.

The phase IV clinical study analyzes which people have Arachnoid cyst when taking Cymbalta. It is created by eHealthMe based on reports of 145,249 people who have side effects when taking Cymbalta from the FDA, and is updated regularly.

What is Cymbalta?

Cymbalta has active ingredients of duloxetine hydrochloride. It is often used in depression. eHealthMe is studying from 154,976 Cymbalta users. Check the latest studies of Cymbalta.

What is Arachnoid cyst?

Arachnoid cyst is found to be associated with 70 drugs and 76 conditions by eHealthMe. Check the latest studies of Arachnoid cyst.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 03, 2026

145,249 people reported to have side effects when taking Cymbalta.
Among them, 11 people (0.01%) have Arachnoid cyst.

Among these 11 people:

How long have people been on Cymbalta when they have Arachnoid cyst? *

What is the gender of people who have Arachnoid cyst when taking Cymbalta? *

female: 72.73 %
male: 27.27 %

What is the age of people who have Arachnoid cyst when taking Cymbalta? *

What are other drugs people take besides Cymbalta? *

What are other side effects people have besides Arachnoid cyst? *

Fatigue (feeling of tiredness): 6 people, 54.55%
Headache (pain in head): 5 people, 45.45%
Nausea And Vomiting: 5 people, 45.45%
Nausea (feeling of having an urge to vomit): 5 people, 45.45%
Memory Loss: 5 people, 45.45%
Pain: 5 people, 45.45%
Malaise (a feeling of general discomfort or uneasiness): 5 people, 45.45%
Drug Ineffective: 4 people, 36.36%
Transient Ischaemic Attack (a transient episode of neurologic dysfunction caused by ischemia (loss of blood flow)): 4 people, 36.36%
Urinary Incontinence (inability to control the flow of urine and involuntary urination): 4 people, 36.36%

What are the existing conditions these people have? *

Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 4 people, 36.36%
Pain: 3 people, 27.27%
Muscle Spasticity (tight or stiff muscles and an inability to control those muscles): 2 people, 18.18%
Muscle Spasms (muscle contraction): 1 person, 9.09%
Bipolar Disorder (mood disorder): 1 person, 9.09%
Back Pain: 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Cymbalta and have Arachnoid cyst?

- Check whether Arachnoid cyst is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Cymbalta:

Cymbalta (154,976 reports)

Browse all side effects of Cymbalta:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Arachnoid cyst:

Arachnoid cyst (70 drugs)

Browse all the conditions that are associated with Arachnoid cyst:

Arachnoid cyst (76 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on duloxetine hydrochloride (the active ingredients of Cymbalta) and Cymbalta (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.